Phosphatidacylhydrolase as a virulence factor of opportunistic microorganisms in lipoconjugate hydrolysis reactions
https://doi.org/10.29235/1561-8323-2026-70-1-32-44
Abstract
For the first time, phosphatidyl derivatives of a number of nucleosides were studied as substrates of phosphatidylacylhydrolase in phospholipolysis reactions. A new trigger mechanism has been proposed and studied that initiates the death of pathogenic and opportunistic microorganisms (Staphylococcus aureus and Candida spp. cells) due to their virulence, including the activity of their own type A phospholipases, under the action of medicinal forms of antibiotics (based on covalently and non-covalently modified lipoconjugates) of the purine (nelarabine, nitrogenous base guanine) and pyrimidine (brivudine, nitrogenous base uracil) series, which have a bactericidal effect. In terms of the resistance of forms to destruction in the digestive tract, it has been shown that brivudine lipoconjugates are most susceptible to hydrolysis with the participation of pancreatic phospholipase A2, while nelarabine-based lipoconjugate is characterized by higher stability to phospholipolysis. It has been established that, since the rate of hydrolysis of lipoconjugates of nelarabine and brivudine by phospholipase A of the culture fluid of Candida sake and Staphylococcus aureus is 1.7 and 2 times higher, respectively, than that of phosphatidylcholine, they can serve as a basis for the demonstration of biocide-containing conjugates and facilitate the availability of the active substance due to increased hydrolyzability.
About the Authors
N. M. LitvinkoBelarus
Litvinko Natalia M. – D. Sc. (Chemistry), Professor, Head of the Laboratory.
5/2, Kuprevich Str., 220084, Minsk
D. O. Gerlovsky
Belarus
Gerlovsky Denis O. – Ph. D. (Chemistry), Assistant Professor, Researcher.
5/2, Kuprevich Str., 220084, Minsk
I. A. Mikhailopulo
Russian Federation
Mikhailopulo Igor A. – Corresponding Member, D. Sc. (Chemistry), Chief Researcher.
5/2, Kuprevich Str., 220084, Minsk
References
1. Pakbin B., Brück W. M., Rossen J. W. A. Virulence factors of enteric pathogenic Escherichia coli: a review. International Journal of Molecular Sciences, 2021, vol. 22, no. 18, art. 9922. https://doi.org/10.3390/ijms22189922
2. Dennis E. A. Allosteric regulation by membranes and hydrophobic subsites in phospholipase A2 enzymes determine their substrate specificity. Journal of Biological Chemistry, 2022, vol. 28, no. 5, art. 101873. https://doi.org/10.1016/j.jbc.2022.101873
3. Flores-Díaz M., Monturiol-Gross L., Naylor C., Alape-Girón A., Flieger A. Bacterial sphingomyelinases and phospholipases as virulence factors. Microbiology and Molecular Biology Reviews, 2016, vol. 80, no. 3, pp. 597–628. https://doi.org/10.1128/mmbr.00082-15
4. Thomson J. M., Lamont I. L. Nucleoside analogues as antibacterial agents. Frontiers in Microbiology, 2019, vol. 10, art. 952. https://doi.org/10.3389/fmicb.2019.00952
5. Zhuang J., Ma S. Recent development of pyrimidine-containing antimicrobial agents. ChemMedChem, 2020, vol. 15, no. 20, pp. 1875–1886. https://doi.org/10.1002/cmdc.202000378
6. Zhu X., Tang Q., Zhou X., Momeni M. R. Antibiotic resistance and nanotechnology: A narrative review. Microbial Pathogenesis, 2024, vol. 193, art. 106741. https://doi.org/10.1016/j.micpath.2024.106741
7. Artsemyeva J. N., Remeeva E. A., Buravskaya T. N., Konstantinova I. D., Esipov R. S., Miroshnikov A. I., Litvinko N. M., Mikhailopulo I. A. Anion exchange resins in phosphate form as versatile carriers for the reactions catalyzed by nucleoside phosphorylases. Beilstein Journal of Organic Chemistry, 2020, vol. 16, pp. 2607–2622. https://doi.org/10.3762/bjoc.16.212
8. Marennikova S. S., Matsevich G. R., Chekunova E. V., Nikulina V. G., Mikhailopulo I. A., Gorbovitskaya G. E., Kulak T. I. Therapeutic effect of bromvinyldeoxyuridine and several nucleotides during experimental herpetic infection. Acta Virologica, 1984, vol. 28, no. 6, art. 522. PMID: 6152132
9. Bergelson L. D., Dyatlovitskaya E. V., Molotkovsky Yu. G. Preparative Biochemistry of Lipids. Moscow, 1981 (in Russian).
10. Vaskovsky V. E., Kostetsky E. Y., Vasendin J. M. A universal reagent for phospholipid analysis. Journal of Chromatography, 1975, vol. 114, no. 1, pp. 129–141. https://doi.org/10.1016/s0021-9673(00)85249-8
11. Sizentsov A. N. Methods for Determining Antibiotic Productivity and Antibiotic Resistance. Orenburg, 2009. 107 p. (in Russian).
12. Mikhailopulo I. A., Miroshnikov А. I. New trends in nucleoside biotechnology. ActaNaturae, 2010, vol. 2, no. 2, pp. 36–58. https://doi.org/10.32607/20758251-2010-2-2-36-58
13. Yates M. K., Seley-Radtke K. L. The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold. Antiviral Research, 2019, vol. 162, pp. 5–21. https://doi.org/10.1016/j.antiviral.2018.11.016
14. Feng J. Y. Addressing the selectivity and toxicity of antiviral nucleosides. Antiviral Chemistry and Chemotherapy, 2018, vol. 26, art. 2040206618758524. https://doi.org/10.1177/2040206618758524
15. Litvinko N. M. Inhibition of phospholipase A2 by Virasole derivation. Doklady Natsional’noi akademii nauk Belarusi = Doklady of the National Academy of Sciences of Belarus, 2021, vol. 65, no. 3, pp. 309–319 (in Russian). https://doi.org/10.29235/1561-83232021-65-3-309-319
16. Salim A., Farooq M. O., Mengal F. U. A., Malik K. Sofosbuvir-based treatment for HCV: a safe option in patients undergoing hemodialysis. Journal of the College of Physicians and Surgeons Pakistan, 2020, vol. 30, no. 11, pp. 1230–1231. https://doi.org/10.29271/jcpsp.2020.11.1230
17. Shimony Sh., DeAngelo D. J., Luskin M. R. Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia. Blood Advances, 2024, vol. 8, no. 1, pp. 23–36. https://doi.org/10.1182/bloodadvances.2023010303
18. Litvinko N. M. Role of purine and pyrimidine nucleosides and their derivatives in reactions catalyzed by pancreatic phospholipase A2. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seryya khimichnykh navuk = Proceedings of the National Academy of Sciences of Belarus. Chemical Series, 2022, vol. 58, no. 1, рр. 105–128 (in Russian). https://doi.org/10.29235/1561-8331-2022-58-1-105-128
19. Gerlovsky D. O., Rasich V. A., Litvinko N. M. Activation of prodrugs constructed on the basis of phospholipids in the composition of various nanoparticles. Novosti mediko-biologicheskikh nauk = News of Medical and Biological Sciences, 2023, no. 3, pp. 25–26 (in Russian).
20. Cordeiro R. A., Teixeira C. E. C., Brilhante R. S. N., Castelo-Branco D. S. C. M., Paiva M. A. N., Giffoni Leite J. J., Lima D. T., Monteiro A. J., Sidrim J. J. C., Rocha M. F. G. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. Medical Mycology, 2013, vol. 51, no. 1, pp. 53–59. https://doi.org/10.3109/13693786.2012.692489
Review
JATS XML





































